Literature DB >> 19734321

N6-substituted cAMP analogs inhibit bTREK-1 K+ channels and stimulate cortisol secretion by a protein kinase A-independent mechanism.

Haiyan Liu1, Judith A Enyeart, John J Enyeart.   

Abstract

Bovine adrenal zona fasciculata (AZF) cells express bTREK-1 K+ channels whose inhibition by cAMP is coupled to membrane depolarization and cortisol secretion through complex signaling mechanisms. cAMP analogs with substitutions in the 6 position of the adenine ring selectively activate cAMP-dependent protein kinase (PKA) but not exchange proteins activated by cAMP (Epacs). In whole-cell patch-clamp recordings from AZF cells, we found that 6-benzoyl-cAMP (6-Bnz-cAMP) and 6-monobutyryl-cAMP potently inhibit bTREK-1 K+ channels, even under conditions in which PKA activity was abolished. Specifically, when applied through the patch electrode, 6-Bnz-cAMP inhibited bTREK-1 with an IC(50) of less than 0.2 microM. Inhibition of bTREK-1 by 6-Bnz-cAMP was not diminished by PKA antagonists, including N-[2-(4-bromocinnamylamino)ethyl]-5-isoquinoline (H-89), adenosine 3'-5'cyclic monophosphothiate, Rp-isomer, protein kinase inhibitor (PKI) (6-22) amide, and myristoylated PKI (14-22), applied alone or in combination, externally and intracellularly through the patch pipette. Under similar conditions, these same antagonists completely blocked PKA activation by 6-Bnz-cAMP. Inhibition of bTREK-1 by 6-Bnz-cAMP was voltage-independent and eliminated in the absence of ATP in the pipette solution. 6-Bnz-cAMP also produced delayed increases in cortisol synthesis and the expression of CYP11a1 mRNA that were only partially blocked by PKA antagonists. These results indicate that 6-Bnz-cAMP and other 6-substituted cAMP analogs can inhibit bTREK-1 K+ channels and stimulate delayed increases in cortisol synthesis by AZF cells through a PKA- and Epac-independent mechanism. They also suggest that adrenocorticotropin and cAMP function in these cells through a third cAMP-dependent protein. Finally, although 6-modified cAMP analogs exhibit high selectivity in activating PKA over Epac, they also may interact with other unidentified proteins expressed by eukaryotic cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19734321      PMCID: PMC2784727          DOI: 10.1124/mol.109.057075

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  38 in total

1.  Thyrotropin activates mitogen-activated protein kinase pathway in FRTL-5 by a cAMP-dependent protein kinase A-independent mechanism.

Authors:  L Iacovelli; L Capobianco; L Salvatore; M Sallese; G M D'Ancona; A De Blasi
Journal:  Mol Pharmacol       Date:  2001-11       Impact factor: 4.436

2.  A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK.

Authors:  Jorrit M Enserink; Anne E Christensen; Johan de Rooij; Miranda van Triest; Frank Schwede; Hans Gottfried Genieser; Stein O Døskeland; Jonathan L Blank; Johannes L Bos
Journal:  Nat Cell Biol       Date:  2002-11       Impact factor: 28.824

3.  ERKs regulate cyclic AMP-induced steroid synthesis through transcription of the steroidogenic acute regulatory (StAR) gene.

Authors:  S L Gyles; C J Burns; B J Whitehouse; D Sugden; P J Marsh; S J Persaud; P M Jones
Journal:  J Biol Chem       Date:  2001-06-15       Impact factor: 5.157

4.  Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes.

Authors:  R Buscà; P Abbe; F Mantoux; E Aberdam; C Peyssonnaux; A Eychène; J P Ortonne; R Ballotti
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

5.  New signaling pathway for parathyroid hormone and cyclic AMP action on extracellular-regulated kinase and cell proliferation in bone cells. Checkpoint of modulation by cyclic AMP.

Authors:  Takashi Fujita; Toru Meguro; Ryo Fukuyama; Hiromichi Nakamuta; Masao Koida
Journal:  J Biol Chem       Date:  2002-04-15       Impact factor: 5.157

Review 6.  Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation.

Authors:  Philip J S Stork; John M Schmitt
Journal:  Trends Cell Biol       Date:  2002-06       Impact factor: 20.808

7.  A novel K+ current inhibited by adrenocorticotropic hormone and angiotensin II in adrenal cortical cells.

Authors:  B Mlinar; B A Biagi; J J Enyeart
Journal:  J Biol Chem       Date:  1993-04-25       Impact factor: 5.157

8.  Corticotropin induces the expression of TREK-1 mRNA and K+ current in adrenocortical cells.

Authors:  Judith A Enyeart; Sanjay Danthi; John J Enyeart
Journal:  Mol Pharmacol       Date:  2003-07       Impact factor: 4.436

9.  cAMP analog mapping of Epac1 and cAMP kinase. Discriminating analogs demonstrate that Epac and cAMP kinase act synergistically to promote PC-12 cell neurite extension.

Authors:  Anne E Christensen; Frode Selheim; Johan de Rooij; Sarah Dremier; Frank Schwede; Khanh K Dao; Aurora Martinez; Carine Maenhaut; Johannes L Bos; H-G Genieser; Stein O Døskeland
Journal:  J Biol Chem       Date:  2003-06-20       Impact factor: 5.157

10.  An ACTH- and ATP-regulated background K+ channel in adrenocortical cells is TREK-1.

Authors:  John J Enyeart; Lin Xu; Sanjay Danthi; Judith A Enyeart
Journal:  J Biol Chem       Date:  2002-10-03       Impact factor: 5.157

View more
  4 in total

Review 1.  Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.

Authors:  William G Robichaux; Xiaodong Cheng
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

2.  cAMP analogs and their metabolites enhance TREK-1 mRNA and K+ current expression in adrenocortical cells.

Authors:  Judith A Enyeart; Haiyan Liu; John J Enyeart
Journal:  Mol Pharmacol       Date:  2009-12-22       Impact factor: 4.436

Review 3.  Two-pore domain potassium channels in the adrenal cortex.

Authors:  Sascha Bandulik; Philipp Tauber; Enzo Lalli; Jacques Barhanin; Richard Warth
Journal:  Pflugers Arch       Date:  2014-10-23       Impact factor: 3.657

Review 4.  Protein Kinase Inhibitor Peptide as a Tool to Specifically Inhibit Protein Kinase A.

Authors:  Chong Liu; Ping Ke; Jingjing Zhang; Xiaoying Zhang; Xiongwen Chen
Journal:  Front Physiol       Date:  2020-11-25       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.